Search bioRxiv⌕ Search

bioRxiv · 10.1101/2025.05.08.652590

Monocyte single cell-type gene expression measured in peripheral blood by DIRECT LS-TA method: the ratio-based biomarkers of (IFI27/PSAP) showed superior performance than interferon score in triage patients with viral infection

Abstract

A rapid method to triage febrile patients into different categories of etiologies remains a significant challenge even nowadays, when many molecular tests for pathogens are available. Routine serum protein tests like C-reactive protein and procalcitonin have limited specificity. Host response gene signatures are promising biomarkers but they usually require assaying many genes, e.g. 7 genes are commonly used to calculate the interferon (IFN) score. However, these gene panels fail to capture cell-type-specific host responses. Measuring gene expression of a specified single cell population, like monocytes, offers enhanced biological insight. However, it currently requires laborious cell sorting or costly single-cell sequencing techniques, limiting its clinical applicability. This study aims to develop a simple ratio-based biomarker (RBB) representing monocyte-specific host response to viral infection called DIRECT LS-TA method. A simple ratio of 2 genes (both are shortlist monocyte informative genes) quantified in peripheral blood (PB) samples correlated with gene expression in purified monocytes in the corresponding individual. These RBBs cover 3 interferon-stimulated genes (ISGs): IFI27/PSAP, IFI44L/PSAP and SIGLEC1/PSAP. They are compared to the conventional multi-gene IFN score in the differentiation of viral infection. Public gene expression datasets from NCBI GEO were used to shortlist monocyte-informative genes that can be used as the RBB in PB. The DIRECT LS-TA RBB was calculated as the ratio of the target ISG transcript abundance (TA) to that of another reference gene (PSAP or CTSS) directly quantified from bulk PB data (e.g., Log(IFI27/PSAP) in WB). The correlation (expressed by coefficient of determination, R{superscript 2}) between these DIRECT LS-TA RBBs and the gold-standard target gene TA measured in purified monocytes was assessed. The diagnostic performance of selected RBBs (IFI27/PSAP, IFI44L/PSAP, SIGLEC1/PSAP) was compared against the conventional 8-gene IFN score for differentiating viral infections from controls. Direct LS-TA RBBs measured in PB showed strong correlation with gold-standard gene expression measured in purified monocytes (R2 ranged from 0.53 for the target gene IFI27 to >0.9 for the target gene IFI44L). This high level of correlation supports that this simple RBB (DIRECT LS-TA) method can replace the tedious cell sorting approach to obtain single-cell-type gene expression data. All DIRECT LS-TA results of ISGs were raised during viral infection. The best clinical performance in triaging viral infection patients was achieved by IFI27/PSAP or IFI27/CTSS across all datasets. For example, in the GSE111368 dataset, IFI27/PSAP achieved an AUC of 0.94 (95% CI 0.90-0.97) with 88% sensitivity and 95% specificity, surpassing the IFN scores AUC of 0.90 (95% CI 0.85-0.94) with 79% sensitivity and 93% specificity. ConclusionThe DIRECT LS-TA method, utilizing the format of simple two-gene ratio-based biomarkers like IFI27/PSAP, provides a robust and accurate measure of monocyte-specific interferon pathway activation directly from peripheral blood. The superior performance of the DIRECT LS-TA method makes it a promising, readily implementable tool for clinical triage. Its ability to provide single-cell-type specific information, rapid turnaround using standard qPCR/dPCR technology, and enhanced biological specificity make it a valuable molecular host response assessment.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Tang, N. L.-s., Kwan, T.-K., Huang, D., Huang, J., Wang, X., Lui, G. C., Ma, S.-L., Leung, K.-S.. 2025-05-11. Monocyte single cell-type gene expression measured in peripheral blood by DIRECT LS-TA method: the ratio-based biomarkers of (IFI27/PSAP) showed superior performance than interferon score in triage patients with viral infection. https://doi.org/10.1101/2025.05.08.652590

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Melanoma suppresses galectin-9-glycan axis in dendritic cells and galectin-9 restoration limits T regulatory cell expansion

Dendritic cells (DCs) are key orchestrators of anti-tumor adaptive immune responses. Their function is tightly regulated by galectins, a family of carbohydrate-biding proteins that decode extracellular glycans into intracellular signaling. Here, we show that exposure to melanoma-conditioned media (CM) induces loss of galectin-9 (gal-9) at the DC surface. Notably, gal-9 loss, independent of transcriptional regulation, was associated with the acquisition of an immunosuppressive phenotype in CD14cDC2 cells following tumor exposure, with higher-molecular weight fractions of the melanoma secretome as mediators. Notably, gal-9 depletion was mirrored with a reduction in gal-9 ligands on the cell surface, particularly GalNAc-containing glycoepitopes, pointing towards a melanoma-exploited gal-9-glycan axis as a DC-evasive strategy. Interestingly, restoring gal-9 surface levels in CM-exposed CD14cDC2 cells prevented the expansion of regulatory T cells (Tregs), postulating gal-9 as a novel immunomodulatory molecule in DC-mediated Treg induction during melanoma progression. Altogether, our data suggest that melanoma-derived factors remodel the DC glycan-gal-9 axis to enhance T cell differentiation towards regulatory phenotypes and dampen anti-tumor immunity. This identifies the gal-9/glycan axis in CD14cDC2 cells as a vulnerable node in melanoma immune evasion and as a potential therapeutic target.

immunology↗

Repeated shrimp allergen exposure drives 5-lipoxygenase-dependent avoidance and selective gut-brain activation

Peripheral immune processes can shape animal behavior, yet how noninfectious inflammatory reactions affect neural activity and behavioral outputs remains poorly understood. We developed an optimized murine model of shrimp allergy using whole shrimp extract to examine how a complex dietary allergen elicits integrated immune, neural, and behavioral responses. Sensitized mice received repeated oral shrimp challenges and were assessed for allergic pathology, food preference, affective-like behaviors, and neuronal activation in the brain. Repeated exposure increased total IgE and shrimp-specific IgG1, induced mast cell activation, accelerated gastrointestinal transit, caused mild hypothermia consistent with oral anaphylaxis, and increased intestinal length. Shrimp-sensitized mice did not avoid shrimp solution after sensitization alone. Instead, avoidance emerged only after repeated oral challenges and strengthened over time. This delayed aversion occurred without detectable changes in locomotor activity or measures of anxiety-like or depressive-like behavior at the time points tested. Repeated shrimp exposure increased cFOS expression in the area postrema, nucleus of the tractus solitarius, central amygdala, and paraventricular nucleus of the thalamus, implicating brainstem and limbic-thalamic pathways involved in visceral sensing and aversion. Pharmacological inhibition of 5-lipoxygenase partially reversed avoidance and reduced circulating mast cell protease-1 in allergic mice. These findings establish a robust whole-shrimp allergy model and show that a complex food allergen engages gut-brain pathways to promote 5-lipoxygenase-dependent avoidance. The delayed, selective nature of this response supports immune-mediated food aversion as a shared output of food allergy, while suggesting that its kinetics and neural recruitment vary with allergen identity and inflammatory context.

immunology↗

Targeting IL-2 to inflamed tissues via oxidation-specific epitopes enables third-generation bispecific IL-2 therapeutics

Interleukin-2 (IL-2) is essential for the survival and activation of regulatory T cells (Tregs). Low-dose native IL-2 (IL-2LD) therapy restores immune regulation in vivo and has shown reproducible clinical benefit across multiple autoimmune, inflammatory, and neuroimmune diseases. Attempts to improve IL-2 through engineered variants (muteins) have mainly focused on enhancing Treg selectivity by reducing IL-2 receptor {beta}-chain binding, but this strategy profoundly diminishes biological potency, likely contributing to the limited clinical efficacy of IL-2 muteins. Here, we develop a ''third-generation IL-2'' that combines site-specific targeting and bifunctionality. We generated a bivalent fusion protein linking IL-2 to a single-chain antibody recognizing oxidation-specific epitopes (OSEs), which are abundantly expressed at inflamed sites. Targeting OSEs provides not only site-specific localization, but also true bifunctionality as both anti-OSE antibodies and IL-2LD independently show therapeutic benefit in limiting inflammation. We first show that IL-2IT has bifunctional biological activities in vitro. In vivo, IL-2IT had increased specificity for Treg over Teff activation, which we attribute to a conformation-dependent modulation of IL-2 receptor engagement. Importantly, IL-2IT provided precise delivery to inflamed tissues in models of psoriasis and colitis. Altogether, this resulted in superior therapeutic benefit in multiple clinical settings, including in atherosclerosis models. Thus, our strategy illustrates a generalizable approach to cytokine engineering that preserves native signaling while achieving spatial control. Specifically, our findings validate OSE targeting as an efficient strategy to guide therapeutics to sites of inflammation and establish OSE-IL-2 as a promising bispecific Treg engager for treating inflammation.

immunology↗